This bill, titled the "Second Chance for Moms Act of 2025," aims to inform women about the potential to counteract the effects of mifepristone. It mandates a conspicuous warning label on mifepristone packaging, advising that medical evidence suggests its abortifacient effects can be counteracted by natural progesterone, which may increase the chance of fetal survival. The label would also note the American Society for Reproductive Medicine's determination that natural progesterone is safe in the first trimester. Furthermore, the legislation establishes a toll-free hotline , operating 24/7, to provide support and information to women seeking to reverse mifepristone's effects. This hotline would exclusively refer callers to healthcare providers specializing in abortion pill reversal services.
Referred to the House Committee on Energy and Commerce.
Health
AbortionConsumer affairsPrescription drugsSex and reproductive healthTelephone and wireless communicationWomen's health
Second Chance for Moms Act
USA119th CongressHR-796| House
| Updated: 1/28/2025
This bill, titled the "Second Chance for Moms Act of 2025," aims to inform women about the potential to counteract the effects of mifepristone. It mandates a conspicuous warning label on mifepristone packaging, advising that medical evidence suggests its abortifacient effects can be counteracted by natural progesterone, which may increase the chance of fetal survival. The label would also note the American Society for Reproductive Medicine's determination that natural progesterone is safe in the first trimester. Furthermore, the legislation establishes a toll-free hotline , operating 24/7, to provide support and information to women seeking to reverse mifepristone's effects. This hotline would exclusively refer callers to healthcare providers specializing in abortion pill reversal services.